Mettler-Toledo International’s (MTD) “Equal Weight” Rating Reiterated at Morgan Stanley
Mettler-Toledo International, Inc. (NYSE:MTD)‘s stock had its “equal weight” rating reissued by equities researchers at Morgan Stanley in a report issued on Saturday. They currently have a $565.00 price objective on the medical instruments supplier’s stock, up from their previous price objective of $533.00. Morgan Stanley’s price target suggests a potential downside of 7.90% from the company’s current price.
A number of other research firms have also commented on MTD. Zacks Investment Research raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $538.00 price objective for the company in a research note on Wednesday, April 12th. Jefferies Group LLC reiterated a “hold” rating and issued a $550.00 target price on shares of Mettler-Toledo International in a report on Tuesday, June 20th. Bank of America Corporation upped their target price on Mettler-Toledo International from $590.00 to $630.00 and gave the company a “buy” rating in a report on Wednesday, May 31st. Cleveland Research upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating in a report on Wednesday, April 19th. Finally, BidaskClub upgraded Mettler-Toledo International from a “buy” rating to a “strong-buy” rating in a report on Wednesday, July 12th. Five analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $523.43.
Shares of Mettler-Toledo International (MTD) opened at 613.49 on Friday. The firm has a market cap of $15.84 billion, a PE ratio of 40.03 and a beta of 1.14. Mettler-Toledo International has a 52 week low of $380.35 and a 52 week high of $616.40. The company has a 50 day moving average of $594.37 and a 200 day moving average of $511.84.
Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, May 4th. The medical instruments supplier reported $3.34 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.08 by $0.26. The firm had revenue of $594.57 million during the quarter, compared to analyst estimates of $571.30 million. Mettler-Toledo International had a net margin of 16.04% and a return on equity of 90.28%. Mettler-Toledo International’s revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.46 EPS. On average, equities research analysts anticipate that Mettler-Toledo International will post $17.24 EPS for the current fiscal year.
In other news, CFO Shawn Vadala sold 700 shares of the stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $543.64, for a total value of $380,548.00. Following the completion of the sale, the chief financial officer now directly owns 6,225 shares of the company’s stock, valued at $3,384,159. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Francis A. Contino sold 725 shares of the stock in a transaction that occurred on Monday, May 8th. The shares were sold at an average price of $546.00, for a total value of $395,850.00. Following the completion of the sale, the director now directly owns 2,234 shares of the company’s stock, valued at $1,219,764. The disclosure for this sale can be found here. In the last quarter, insiders have sold 52,046 shares of company stock worth $28,826,702. Corporate insiders own 5.20% of the company’s stock.
Large investors have recently bought and sold shares of the stock. Murphy Capital Management Inc. acquired a new stake in Mettler-Toledo International during the second quarter valued at $235,000. Bedrijfstakpensioenfonds Voor DE Media PNO acquired a new stake in Mettler-Toledo International during the second quarter valued at $1,524,000. Aperio Group LLC boosted its stake in Mettler-Toledo International by 20.7% in the second quarter. Aperio Group LLC now owns 17,643 shares of the medical instruments supplier’s stock valued at $10,384,000 after buying an additional 3,028 shares in the last quarter. Visionary Asset Management Inc. acquired a new stake in Mettler-Toledo International during the second quarter valued at $393,000. Finally, Nisa Investment Advisors LLC boosted its stake in Mettler-Toledo International by 10.3% in the second quarter. Nisa Investment Advisors LLC now owns 16,567 shares of the medical instruments supplier’s stock valued at $9,739,000 after buying an additional 1,547 shares in the last quarter. 95.31% of the stock is owned by institutional investors.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.
Receive News & Ratings for Mettler-Toledo International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.